-
Corporate Governance
Corporate Governance
The members and charters for select committees of Enzon’s Board of Directors.
To report complaints about Enzon’s accounting, internal accounting controls or auditing matters please call 866-276-2949 at any time of the day or night. You may also submit your complaint by e-mailing enzn@openboard.info or writing to:
Enzon Pharmaceuticals, Inc.
Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807You may communicate with Enzon’s Board of Directors by writing to:
Enzon Pharmaceuticals, Inc.
Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) |  | +0.01 | |
| Volume | 261232 | ||
| 1:14 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
12-31-1969
Enzon Reports Strong First Qua...
Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure-- -
01-21-2009
Enzon Concludes Tender Offer f...
Enzon Concludes Tender Offer for a Portion of Its Debt
-
08-11-2008
Enzon Pharmaceuticals Announce...
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business -- -
07-02-2008
Enzon Eliminates its Remaining...
Enzon Eliminates its Remaining 2008 Debt
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
01-28-2009
Enzon Nominates Two New Candid...
Enzon Nominates Two New Candidates for its Board of Directors
-
10-29-2008
Enzon to Release Third Quarter...
Enzon to Release Third Quarter 2008 Earnings on Wednesday, November 5, 2008; Conference Call and Webcast to Follow
-
05-20-2008
Enzon Announces Clinical Data...
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --